Loren Peña

1.8k total citations
25 papers, 601 citations indexed

About

Loren Peña is a scholar working on Physiology, Rheumatology and Molecular Biology. According to data from OpenAlex, Loren Peña has authored 25 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Rheumatology and 6 papers in Molecular Biology. Recurrent topics in Loren Peña's work include Lysosomal Storage Disorders Research (12 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Metabolism and Genetic Disorders (6 papers). Loren Peña is often cited by papers focused on Lysosomal Storage Disorders Research (12 papers), Glycogen Storage Diseases and Myoclonus (8 papers) and Metabolism and Genetic Disorders (6 papers). Loren Peña collaborates with scholars based in United States, United Kingdom and France. Loren Peña's co-authors include Barbara K. Burton, Stephen R. Hooper, Kelly Schoch, Vandana Shashi, Rebecca C. Spillmann, Priya S. Kishnani, Jennifer A. Sullivan, Alan D. Proia, Allyn McConkie‐Rosell and Yong‐Hui Jiang and has published in prestigious journals such as Neurology, The Journal of Pediatrics and BMC Health Services Research.

In The Last Decade

Loren Peña

24 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loren Peña United States 11 261 219 205 170 105 25 601
François Feillet France 15 251 1.0× 248 1.1× 152 0.7× 212 1.2× 97 0.9× 45 685
Ulrike Mütze Germany 18 491 1.9× 321 1.5× 172 0.8× 252 1.5× 155 1.5× 47 750
Carol L. Clow Canada 14 319 1.2× 218 1.0× 141 0.7× 123 0.7× 114 1.1× 23 731
Eva Friedman United States 16 572 2.2× 286 1.3× 70 0.3× 300 1.8× 176 1.7× 33 811
Patricia A. Donohoue United States 16 126 0.5× 480 2.2× 232 1.1× 194 1.1× 31 0.3× 38 943
Ayesha Ahmad United States 13 120 0.5× 151 0.7× 108 0.5× 85 0.5× 62 0.6× 37 392
Matthias Zielonka Germany 15 127 0.5× 195 0.9× 74 0.4× 151 0.9× 33 0.3× 29 451
F. J. van Spronsen Netherlands 13 410 1.6× 215 1.0× 58 0.3× 224 1.3× 77 0.7× 27 504
William Hanley Canada 17 603 2.3× 310 1.4× 83 0.4× 253 1.5× 226 2.2× 29 780
Mark Sharrard United Kingdom 10 178 0.7× 212 1.0× 105 0.5× 73 0.4× 116 1.1× 21 439

Countries citing papers authored by Loren Peña

Since Specialization
Citations

This map shows the geographic impact of Loren Peña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loren Peña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loren Peña more than expected).

Fields of papers citing papers by Loren Peña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loren Peña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loren Peña. The network helps show where Loren Peña may publish in the future.

Co-authorship network of co-authors of Loren Peña

This figure shows the co-authorship network connecting the top 25 collaborators of Loren Peña. A scholar is included among the top collaborators of Loren Peña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loren Peña. Loren Peña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Duong, Tina, Priya S. Kishnani, Kristina An Haack, et al.. (2022). Motor Responses in Pediatric Pompe Disease in the ADVANCE Participant Cohort. Journal of Neuromuscular Diseases. 9(6). 713–730. 3 indexed citations
3.
Byrne, Barry J., Steven D. Colan, Priya S. Kishnani, et al.. (2021). Cardiac responses in paediatric Pompe disease in the ADVANCE patient cohort. Cardiology in the Young. 32(3). 364–373. 6 indexed citations
4.
Dimachkie, Mazen M., Richard J. Barohn, Barry J. Byrne, et al.. (2021). NEO1/NEO-EXT studies: Safety and exploratory efficacy of repeat avalglucosidase alfa dosing after up to 6 years in participants with late-onset pompe disease (LOPD). Molecular Genetics and Metabolism. 132(2). S34–S34. 1 indexed citations
5.
Kishnani, Priya S., James B. Gibson, Michael J. Gambello, et al.. (2019). Clinical characteristics and genotypes in the ADVANCE baseline data set, a comprehensive cohort of US children and adolescents with Pompe disease. Genetics in Medicine. 21(11). 2543–2551. 9 indexed citations
6.
Dimachkie, Mazen M., Richard J. Barohn, Priya S. Kishnani, et al.. (2019). NEO1 AND NEO-EXT STUDIES: PHARMACODYNAMIC/EXPLORATORY BIOMARKER AND SAFETY ASSESSMENTS FOLLOWING REPEAT AVALGLUCOSIDASE ALFA DOSING FOR UP TO 4.5 YEARS IN PATIENTS WITH LATE-ONSET POMPE DISEASE. 60. 1 indexed citations
7.
Nicole, Sophie, Loren Peña, Stephen R. Hooper, et al.. (2018). Characteristics of undiagnosed diseases network applicants: implications for referring providers. BMC Health Services Research. 18(1). 652–652. 23 indexed citations
8.
9.
Spillmann, Rebecca C., Allyn McConkie‐Rosell, Loren Peña, et al.. (2017). A window into living with an undiagnosed disease: illness narratives from the Undiagnosed Diseases Network. Orphanet Journal of Rare Diseases. 12(1). 71–71. 60 indexed citations
10.
11.
Peña, Loren, Sandra C. Van Calcar, Mathew J. Edick, et al.. (2016). Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database. Molecular Genetics and Metabolism. 118(4). 272–281. 65 indexed citations
12.
Kishnani, Priya S., John Day, Michael J. Gambello, et al.. (2016). Clinical characteristics and genotypes in the ADVANCE baseline dataset, a comprehensive cohort of us children and youth with Pompe disease. Molecular Genetics and Metabolism. 117(2). S68–S68. 1 indexed citations
13.
Thurberg, Beth L., Pierre G. Carlier, John T. Kissel, et al.. (2015). A Phase 4 Prospective Study in Patients with Adult Pompe Disease Treated with Alglucosidase Alfa. Journal of Neuromuscular Diseases. 2(s1). S72–S73. 1 indexed citations
14.
Peña, Loren, Alan D. Proia, & Priya S. Kishnani. (2015). Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease. JIMD Reports. 23. 45–54. 38 indexed citations
15.
Stockton, David W., Enikö K. Pivnick, Asim F. Choudhri, et al.. (2015). Premature Pubarche in Children with Pompe Disease. The Journal of Pediatrics. 166(4). 1075–1078.e1. 4 indexed citations
16.
Peña, Loren, Brad Angle, Barbara K. Burton, & Joel Charrow. (2012). Follow-up of patients with short-chain acyl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase deficiencies identified through newborn screening: one center’s experience. Genetics in Medicine. 14(3). 342–347. 22 indexed citations
17.
Peña, Loren & Barbara K. Burton. (2012). Survey of health status and complications among propionic acidemia patients. American Journal of Medical Genetics Part A. 158A(7). 1641–1646. 54 indexed citations
18.
Chapman, Kimberly A., Andrea Gropman, Erin MacLeod, et al.. (2011). Acute management of propionic acidemia. Molecular Genetics and Metabolism. 105(1). 16–25. 71 indexed citations
19.
Sutton, V. Reid, Kimberly A. Chapman, Andrea Gropman, et al.. (2011). Chronic management and health supervision of individuals with propionic acidemia. Molecular Genetics and Metabolism. 105(1). 26–33. 61 indexed citations
20.
Peña, Loren, et al.. (2006). Toxinas naturales:abejas y su veneno. 25(1). 6–10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by François Feillet Breakdown of academic impact, for papers by Ulrike Mütze Breakdown of academic impact, for papers by Carol L. Clow Breakdown of academic impact, for papers by Eva Friedman Breakdown of academic impact, for papers by Patricia A. Donohoue Breakdown of academic impact, for papers by Ayesha Ahmad Breakdown of academic impact, for papers by Matthias Zielonka Breakdown of academic impact, for papers by F. J. van Spronsen Breakdown of academic impact, for papers by William Hanley Breakdown of academic impact, for papers by Mark Sharrard
Rankless by CCL
2026